glp 1 drugs for parkinson's disease Are we measuring the wrong primary outcome GLP-1 for Parkinson's? Spoiler alert: the pooled data suggests we should pivot away from a motor outcome. Should we think cognitive, autonomic, sleep GLP-1 receptor agonists in Parkinson's
Pay in 4 interest-free payments of $5.60 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 26 - Oct 31



















:max_bytes(150000):strip_icc()/health-GettyImages-1498826563-72ccaac18ecf41e49988eccfc823270f.jpg)







